Serum prolactin level in patients taking olanzapine

Serum prolactin level in patients taking olanzapine

Introduction: Olanzapine is a commonly used antipsychotic. Prolactin elevation is a common adverse effect of anstipsychotics, and serum prolactin elevation is seen in about 30% patients treated with olanzapine. There are confounding results about dose dependency of olanzapine and prolactin elevation...

Full description

Bibliographic Details
Main Authors:	Diganta Das, Uddip Talukdar, Syed Javed Salman Chisty, Mantu Kumar Das, Shyamanta Das
Format:	Article
Language:	English
Published:	Academy Publisher 2015-01-01
Series:	Open Journal of Psychiatry and Allied Sciences
Subjects:	Psychotic Disorders Antipsychotic Agents Sex Blood Chemical Analysis
Online Access:	http://dysphrenia.hpage.co.in/ojpas-2015-6-50-58-fulltext_58801855.html

Similar Items

Use of Atypical Antipsychotics in Long-Term Care Residents with Parkinson’s Disease and Comorbid Depression
by: Chekani F, et al.
Published: (2020-01-01)

Olanzapine-induced skin eruptions
by: Nishtha Chawla, et al.
Published: (2017-01-01)

Associations between symptom severity and well-being among Thai patients with schizophrenia: a cross-sectional analytical study
by: Teerapat Teetharatkul, et al.
Published: (2021-07-01)

Acute Generalized Exanthematous Pustulosis Induced by Olanzapine
by: Susanne Christen, et al.
Published: (2006-01-01)

A cross sectional study of trihexyphenidyl utilization on patient receiving antipsychotic therapy
by: Addiniya Nurul Azmi, et al.
Published: (2016-06-01)

Antipsychotic polypharmacy: Retrospective evaluation of cases with psychotic disorder followed in outpatient clinic (tur)
by: Şahabettin Çetin, et al.
Published: (2021-05-01)

Rapid tranquilization for agitated patients in emergency psychiatric rooms: a randomized trial of olanzapine, ziprasidone, haloperidol plus promethazine, haloperidol plus midazolam and haloperidol alone Tranquilização rápida para pacientes agitados nos serviços de emergência psiquiátrica: um ensaio clínico randomisado de olanzapina, ziprasidona, haloperidol mais prometazina, haloperidol mais midazolam e haloperidol em monoterapia
by: Leonardo Baldaçara, et al.
Published: (2011-03-01)

Psychological intervention, antipsychotic medication or a combined treatment for adolescents with a first episode of psychosis: the MAPS feasibility three-arm RCT
by: Anthony P Morrison, et al.
Published: (2021-01-01)

Cigarette smoking and heavy coffee drinking affect therapeutic response to olanzapine
by: Radmanović Branimir, et al.
Published: (2018-01-01)

The comparative efficacy of Haloperidol (IM) plus Lorazepam (PO) and Risperidon plus Lorazepam in the management of acute agitation
by: H.Toofanei (M.D), et al.
Published: (2002-09-01)

Pulmonary thromboembolism and sudden death in psychiatric patients: Two cases reports
by: Marinković Nadica, et al.
Published: (2017-01-01)

Association between the HTR2C rs1414334 C/G gene polymorphism and the development of the metabolic syndrome in patients treated with atypical antipsychotics
by: José María Rico-Gomis, et al.
Published: (2016-07-01)

Paliperidone to Treat Psychotic Disorders
by: Hormazd D. Minwalla, et al.
Published: (2021-07-01)

Hyperlipidemia and metabolic syndrome in schizophrenia:a study of the Northern Finland 1966 Birth Cohort
by: Saari, K. (Kaisa)
Published: (2005)

An exploratory study from eastern India on neurological soft signs and spontaneous movement disorders in schizophrenia spectrum disorders
by: Shyamanta Das, et al.
Published: (2019-01-01)

"For the times they are a-changin'"
by: Shyamanta Das, et al.
Published: (2015-01-01)

Plasma Levels of Long-Acting Injectable Antipsychotics in Outpatient Care: A Retrospective Analysis
by: Hýža M, et al.
Published: (2021-04-01)

Olanzapine-induced neuroleptic malignant syndrome
by: Pradeep Kumar Saha, et al.
Published: (2017-01-01)

Acute olanzapine toxicity in a toddler
by: Hemendra Singh, et al.
Published: (2020-04-01)

The polymorphic variants DRD2 rs1800497 and ABCB1 3435C>T are associated with antipsychotic safety parameters in adolescents with an acute psychotic episode: the results of a pilot study
by: D. V. Ivashchenko, et al.
Published: (2020-10-01)

Analisi farmacoeconomica del trattamento di pazienti psicotici cronici con olanzapina, antipsicotici atipici e neurolettici tipici: uno studio regionale
by: Felice Vadruccio, et al.
Published: (2005-06-01)

Economic Impact of the Application of a Precision Medicine Model (5SPM) on Psychotic Patients
by: Carrascal-Laso L, et al.
Published: (2021-08-01)

Differences between physicians' and nurse practitioners' viewpoints on reasons for clozapine underprescription
by: Cynthia Okhuijsen‐Pfeifer, et al.
Published: (2019-07-01)

Cardiovascular risk screening of patients with serious mental illness or use of antipsychotics in family practice
by: Kirsti M. Jakobs, et al.
Published: (2020-07-01)

Rare and Underestimated Association of Pulmonary Embolism and Olanzapine Therapy; Report of Two Cases
by: Hammam Rasras, et al.
Published: (2021-02-01)

Aripiprazole-induced writer’s cramp: a case report
by: Priyajyoti Chakma, et al.
Published: (2016-07-01)

Olanzapine in the treatment of anorexia nervosa: a systematic review
by: Sidar Çöpür, et al.
Published: (2020-06-01)

Olanzapine induced tardive dyskinesia
by: Rudraprosad Chakraborty, et al.
Published: (2014-01-01)

Olanzapine-induced neutropenia
by: Kirti Malhotra, et al.
Published: (2015-06-01)

Assessment of quality of life in patients with alcohol dependence syndrome
by: Gopal Das Mohan Das Chikkerahally
Published: (2019-01-01)

Assessing effectiveness of aripiprazole lauroxil vs placebo for the treatment of schizophrenia using number needed to treat and number needed to harm
by: Citrome L, et al.
Published: (2019-09-01)

Comparative study of adverse effects of Olanzapine and Risperidone on blood suger, lipid and other side effects in psychotic disorders
by: mitra safa, et al.
Published: (2008-10-01)

Off-label antipsychotics prescription to adolescents with acute psychotic episodes does not cause adverse drug reactions
by: D. V. Ivashchenko, et al.
Published: (2021-06-01)

Polycystic Ovary Syndrome and Psychotic Disorder
by: Larissa Doretto, et al.
Published: (2020-06-01)

Clinical, Biochemical and Genetic Variables Associated With Metabolic Syndrome in Patients With Schizophrenia Spectrum Disorders Using Second-Generation Antipsychotics: A Systematic Review
by: Marius H. Sneller, et al.
Published: (2021-03-01)

Olanzapine Overdose in a Pin Point Pupil with Altered Sensorium
by: Naresh Midha, et al.
Published: (2017-09-01)

Fever, delirium, autonomic instability, and monocytosis associated with olanzapine.
by: Robinson R, et al.
Published: (2003-01-01)

Case of Secondary Tics Associated With Olanzapine in an Adult
by: Eric W. Mills, et al.
Published: (2017-08-01)

The gut microbiome influences the bioavailability of olanzapine in rats
by: Sofia Cussotto, et al.
Published: (2021-04-01)

EFFECT OF TYPICAL AND ATYPICAL ANTIPSYCHOTICS ON PLASMA PROLACTIN LEVELS IN SCHIZOPHRENIA
by: Muhammad Sami Bilal, et al.
Published: (2015-01-01)